Showing results (21-30 of 850) with videos related to
Sort By:
Pageof 85
Current Opinion in Rheumatology|July 15, 2021
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debatePuja Mehta, David C FajgenbaumImmunotherapy|December 5, 2015
Siltuximab: a targeted therapy for idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Razelle KurzrockHematology/Oncology Clinics of North America|November 22, 2017
Castleman Disease PathogenesisDavid C Fajgenbaum, Dustin ShillingHematology. American Society of Hematology. Education Program|December 7, 2024
Identifying Castleman disease from non-clonal inflammatory causes of generalized lymphadenopathySally Nijim, David C FajgenbaumCell Metabolism|August 7, 2020
Teaching Old Drugs New Tricks: Statins for COVID-19?David C Fajgenbaum, Daniel J RaderOncology (Williston Park, N.Y.)|August 16, 2021
The Role of Autologous Stem Cell Transplantation in AmyloidosisIuliana Vaxman, Angela DispenzieriHematology/Oncology Clinics of North America|October 25, 2020
Future PerspectivesAngela Dispenzieri, Giampaolo MerliniPageof 85